Mechanistic studies of tumor-associated macrophage immunotherapy

被引:3
|
作者
Cao, Jiandong [1 ,2 ]
Liu, Chengsen [3 ]
机构
[1] Shenyang Chest Hosp, Dept Thorac Surg, Shenyang, Liaoning, Peoples R China
[2] Tenth Peoples Hosp, Shenyang, Liaoning, Peoples R China
[3] Peoples Hosp Liaoning Prov, Dept Radiotherapy, Shenyang, Liaoning, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
tumor-associated macrophages; TAMs; tumor microenvironment; immunotherapy; cancer; COLONY-STIMULATING FACTOR; CANCER; RECEPTOR; POLARIZATION; ACTIVATION; EXPRESSION; BLOCKADE; CELLS; PROGRESSION; METASTASIS;
D O I
10.3389/fimmu.2024.1476565
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor-associated macrophages (TAMs) are present in the tumor microenvironment and can polarize into subtypes with different functions and characteristics in response to different stimuli, classifying them into anti-tumorigenic M1-type and pro-tumorigenic M2-type. The M1-type macrophages inhibit tumor growth through the release of pro-inflammatory cytokines, whereas the M2-type macrophages contribute to tumor progression through the promotion of tumor proliferation, angiogenesis and metastasis. Due to the duality of macrophage effects on tumors, TAMs have been a hot topic in tumor research. In this paper, the heterogeneity and plasticity of TAMs, the interactions between TAMs and other immune cells, and the effects of TAMs on tumors are reviewed, and the therapeutic strategies for TAMs are summarized and discussed. These therapeutic strategies encompass methods and approaches to inhibit the recruitment of TAMs, deplete TAMs, and modulate the polarization of TAMs. These studies help to deeply understand the mechanism of TAMs-tumor interaction and provide reference for combination therapy of tumors.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Tumor-Associated Carbohydrate Antigens Targeting Immunotherapy
    Matsumoto, Yasuyuki
    TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, 2021, 33 (192) : E33 - E38
  • [32] Targeting tumor-associated acidity in cancer immunotherapy
    Lacroix, Ruben
    Rozeman, Elisa A.
    Kreutz, Marina
    Renner, Kathrin
    Blank, Christian U.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (09) : 1331 - 1348
  • [33] Analysis of gene expression in the tumor-associated macrophage
    Duff, Michael D.
    Mestre, Juan
    Maddali, Sirish
    Yan, Zhao Ping
    Stapleton, Philip
    Daly, John M.
    JOURNAL OF SURGICAL RESEARCH, 2007, 142 (01) : 119 - 128
  • [34] Telomerase as a tumor-associated antigen for cancer immunotherapy
    Patel, KP
    Vonderheide, RH
    CYTOTECHNOLOGY, 2004, 45 (1-2) : 91 - 99
  • [35] Tumor-associated myeloid cells in cancer immunotherapy
    Cheng, Xinyu
    Wang, Huilan
    Wang, Zhongyu
    Zhu, Bo
    Long, Haixia
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [36] Targeting tumor-associated macrophages for cancer immunotherapy
    Shu, Yongheng
    Cheng, Ping
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2020, 1874 (02):
  • [37] Telomerase as a tumor-associated antigen for cancer immunotherapy
    Kunal P. Patel
    Robert H. Vonderheide
    Cytotechnology, 2004, 45 : 91 - 99
  • [38] Tumor-associated fibrosis impairs the response to immunotherapy
    Naik, Angha
    Leask, Andrew
    MATRIX BIOLOGY, 2023, 119 : 125 - 140
  • [39] Tumor-associated monocytes and neutrophils: Targets for immunotherapy
    Jung, Keehoon
    CANCER RESEARCH, 2024, 84 (06)
  • [40] Targeting tumor-associated acidity in cancer immunotherapy
    Ruben Lacroix
    Elisa A. Rozeman
    Marina Kreutz
    Kathrin Renner
    Christian U. Blank
    Cancer Immunology, Immunotherapy, 2018, 67 : 1331 - 1348